Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenCitations
Works that cite this article, indexed by OpenCitations.
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience
Turkish Journal of Gastroenterology 31(4) (2020)
Bilgehan Aygen; Neşe Demirtürk; Orhan Yıldız; Mustafa Kemal Çelen; İlhami Çelik; Şener Barut; Onur Ural; Ayşe Batırel; Reşit Mıstık; Funda Şimşek; Ali Asan; Gülden Ersöz; Nesrin Türker; Hüseyin Bilgin; Sami Kınıklı; Faruk Karakeçili; Gökmen Zararsız
HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
Viruses 14(3) (2022)
Robert Flisiak; Dorota Zarębska-Michaluk; Egle Ciupkeviciene; Sylvia Drazilova; Sona Frankova; Ivica Grgurevic; Bela Hunyady; Peter Jarcuska; Limas Kupčinskas; Michael Makara; Gunita Saulite-Vanaga; Marieta Simonova; Jan Sperl; Ieva Tolmane; Adriana Vince
High success rates for the use of ombitasvir/paritaprevir/ritonavir containing regimens in treatment of naïve and experienced chronic hepatitis C genotype 4: Real world results
Journal of Medical Virology 94(2) (2019)
Mohamed El Kassas; Mohamed Alboraie; Heba Omar; Yasmeen Abd El Latif; Mohammed Abd Algaber; Adel El Tahan; Hesham El Halwagy; Shimaa Afify; Magdy Elserafy; Kadry Elsaeed; Wahid Doss